NCT01112982 An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels. Status COMPLETED Phase PHASE4
NCT01052987 Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia Status COMPLETED Phase PHASE2
NCT00995618 Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia Status COMPLETED Phase PHASE2
NCT00985127 Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout Status COMPLETED Phase PHASE2
NCT00958438 PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2) Status COMPLETED Phase PHASE3
NCT00856206 Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE) Status COMPLETED Phase PHASE3
NCT00819585 A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study) Status COMPLETED Phase PHASE2
NCT00610363 Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares Status COMPLETED Phase PHASE2
NCT00584311 MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs Status COMPLETED Phase NA
NCT00430248 Efficacy and Safety of Oral Febuxostat in Participants With Gout Status COMPLETED Phase PHASE3
NCT00325195 Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout Status COMPLETED Phase PHASE3
NCT00175019 Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010 Status COMPLETED Phase PHASE3
NCT00174967 Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout Status COMPLETED Phase PHASE2